Autoimmune Polyglandular Syndrome Type 1

Search Trials
Tyrosine Hydroxylase Antibody Levels in Autoimmune Polyglandular Syndrome Type 1 Associated Keratitis
Status:
Completed
Last Changed:
May 5, 2020
First Changed:
May 5, 2020
Disease(s):
Autoimmune Polyglandular Syndrome Type I
Intervention(s):
Detection of autoantibodies
Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
Status:
Not yet recruiting
Last Changed:
May 28, 2021
First Changed:
May 26, 2021
Disease(s):
Autoimmune Lymphoproliferative Syndrome
Intervention(s):
Collection of samples
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Dec 21, 2021
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Characterization of the Fungal Origins in the Autoimmune Polyendocrinopathy of Type 1 Compared With the Autoimmune Polyendocrinopathies of Type 2
Status:
Recruiting
Last Changed:
Feb 16, 2022
First Changed:
Jan 10, 2019
Disease(s):
Polyendocrinopathies, Autoimmune

Connect. Empower. Inspire.